Biomira (BRA.TO)

DON'T BUY
No earnings Speculative play Loss because of research costs
DON'T BUY
News driven. Have to have good balance sheets
STRONG BUY
Undervalued. Market waiting for a partner & test results. Should be there by year end
Showing 16 to 18 of 18 entries